Showing 15,901 - 15,920 results of 32,444 for search '(( 50 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( a step decrease ))', query time: 1.22s Refine Results
  1. 15901
  2. 15902

    Table1_Relationship between serum uric acid levels and uric acid lowering therapy with the prognosis of patients with heart failure with preserved ejection fraction: a meta-analysi... by Linzhi Li (697796)

    Published 2024
    “…However, it was associated with a decreased risk of hospitalization due to HF (RR: 0.85, 95% CI: 0.79–0.91, P < 0.001).…”
  3. 15903

    Image1_A Novel Age-Related Circular RNA Circ-ATXN2 Inhibits Proliferation, Promotes Cell Death and Adipogenesis in Rat Adipose Tissue-Derived Stromal Cells.JPEG by Xing-Hui Song (11665903)

    Published 2021
    “…Our study revealed the expression profile of circRNAs in the adipose tissue of old rats. We found a novel age-related circular RNA—circ-ATXN2—that inhibits proliferation and promotes cell death and adipogenesis in rat adipose tissue-derived stromal cells.…”
  4. 15904

    Data_Sheet_1_Increased CO2 Relevant to Future Ocean Acidification Alleviates the Sensitivity of a Red Macroalgae to Solar Ultraviolet Irradiance by Modulating the Synergy Between P... by Di Zhang (197959)

    Published 2021
    “…By using chlorophyll fluorescence techniques, we found that high levels of PAR alone induced photoinhibition of the inter-photosystem electron transport carriers, as evidenced by the increase of chlorophyll fluorescence in both the J- and I-steps of Kautsky curves. In the presence of UVR, photoinduced inhibition was mainly identified in the O<sub>2</sub>-evolving complex (OEC) and PSII, as evidenced by a significant increase in the variable fluorescence at the K-step (F<sub>k</sub>) of Kautsky curves relative to the amplitude of F<sub>J</sub>−F<sub>o</sub> (W<sub>k</sub>) and a decrease of the maximum quantum yield of PSII (F<sub>v</sub>/F<sub>m</sub>). …”
  5. 15905
  6. 15906

    DataSheet1_Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice.pdf by Rongjie Zhang (5625083)

    Published 2022
    “…Here, we discovered that sodium tanshinone IIA sulfonate (STS), a sulfonate derived from tanshinone IIA (TSN), reduced the enzymatic activities of IDO1 and TDO2 with a half inhibitory concentration (IC<sub>50</sub>) of less than 10 μM using enzymatic assays for natural product screening. …”
  7. 15907

    Data_Sheet_1_The effect of omega-3 fatty acids and its combination with statins on lipid profile in patients with hypertriglyceridemia: A systematic review and meta-analysis of ran... by Yunjiao Yang (4966963)

    Published 2022
    “…Background/Aim<p>Omega-3 fatty acids (OM3-FA), a promising treatment for high triglycerides, have gradually attracted public attention. …”
  8. 15908

    Supplementary materials: Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapies for late-onset Pompe disease: a network meta-analysis... by Simon Shohet (17882674)

    Published 2024
    “…<b>Results:</b> Network B (full evidence analysis) showed that cipa+mig was associated with a relative increase in 6MWD (mean difference 28.93 m, 95% credible interval [8.26–50.11 m]; Bayesian probability 99.7%) and FVC (2.88 pp [1.07–4.71 pp]; >99.9%) compared with aval. …”
  9. 15909
  10. 15910
  11. 15911
  12. 15912

    Data_Sheet_1_Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head a... by Sati Akbaba (7213499)

    Published 2019
    “…While bimodal RT for ITAC resulted in a significantly decreased 3-year LC rate of 50 vs. 93% for each SGAC and SDAC (p < 0.01), no statistical significant survival differences could be identified across the three groups regarding OS (p = 0.08) and PFS (p = 0.063). 3-year OS was 88% for SGAC, 78% for SDAC and 67% for ITAC and 3-year PFS was 72% for SGAC, 53% for SDAC and 44% for ITAC, respectively. …”
  13. 15913

    Data_Sheet_2_Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head a... by Sati Akbaba (7213499)

    Published 2019
    “…While bimodal RT for ITAC resulted in a significantly decreased 3-year LC rate of 50 vs. 93% for each SGAC and SDAC (p < 0.01), no statistical significant survival differences could be identified across the three groups regarding OS (p = 0.08) and PFS (p = 0.063). 3-year OS was 88% for SGAC, 78% for SDAC and 67% for ITAC and 3-year PFS was 72% for SGAC, 53% for SDAC and 44% for ITAC, respectively. …”
  14. 15914
  15. 15915

    DataSheet_1_Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma.pdf by Paul D. Bates (7178726)

    Published 2021
    “…<p>Management for high-risk neuroblastoma (NBL) has included autologous hematopoietic stem cell transplant (HSCT) and anti-GD2 immunotherapy, but survival remains around 50%. The aim of this study was to determine if allogeneic HSCT could serve as a platform for inducing a graft-versus-tumor (GVT) effect against NBL with combination immunocytokine and NK cells in a murine model. …”
  16. 15916

    DataSheet_1_Dynamic Change of Thyroid Hormones With Postmenstrual Age in Very Preterm Infants Born With Gestational Age <32 Weeks: A Multicenter Prospective Cohort Study.pdf by Ranran Shi (10498970)

    Published 2021
    “…The results prompt that age-related cutoffs, instead of a single reference range, might be more useful to explain the thyroid function of VPIs. …”
  17. 15917

    DataSheet_1_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.doc by Mengting Chen (1419172)

    Published 2023
    “…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”
  18. 15918
  19. 15919
  20. 15920